Genmab A/S

kr 3,527As of Sun 8 Nov 2026, 12:00 UTC
CPH:GMABHealthcare
Country Denmark
PE (Fwd) •••
TSR 10Y CAGR 12.15%
Div yield —
ROE 12.07%
Biotechnology
Beta (5Y) 0.52
PE TTM 45.84
TSR TTM 91.89%
Mkt cap kr 223.2B
ROIC 12.73%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 4,317
22.41%
340.19%
Hold 1|10|6|4|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
84.02
85.67
94.88
105.36
9.23%
1.24%
14.59%
23.40%
Revenue$B
16.19
16.11
16.93
17.05
9.90%
12.03%
11.39%
10.44%
Peers (US$33.28B)
Cap (US$)
PE
16.87B
19.19x
8.031B
39.82x
2.720B
12.41x
35.54B
30.85x
Capital
TTM
5Y
10Y
Leveragex
0.832
(0.033)
(0.031)
EBIT/Intx
0.853
0.074
0.087
Own earn%
(69.29)
(36.98)
(27.47)
Sh yield%
42.89
48.82
51.52
Owners
Insiders/Inst%
1.96
69.23
Short interest%
2.06
SBC / revenue%
1.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
23–29
$1 testx
1.5
Incr. ROIC%
2